References
- Jung JK, Jung HM, Seo WG, Park YK. Anti-allergic effect of Osterici Radix water extract in human mast cells. Kor J Herbology. 2010 ; 25(3) : 35-41.
- Korean Journal of Asthma, Allergy and Clinical Immunology. Asthma and Allergy disease. Seoul : koonja publisher. 2002 ; 66 : 431-3.
- Seoul National University College of Medicine. Immunology. Seoul : Seoul National University publisher. 1987 : 188-97.
- Harvima IT, Nilsson G. Mast cells as regulators of skin inflammation and immunity. Acta Derm Venereol. 2011 ; 91(6) : 644-50. https://doi.org/10.2340/00015555-1197
- Ahn K. Role of mast cells in allergic inflammation and innate immunity. Kor J Pediatrics. 2004 ; 47(11) : 1137-41.
- Church MK, Bradding P, Walls AF, Okayama Y. Human mast cells and basophils. In Allergy and allergic diseases. 1st ed. MA : Blackwell Science. 1997 : 149-70.
- Trefzer U, Hofmann M, Sterry W, Asadullah K. Cytokine and anti-cytokine therapy in dermatology. Expert opin Biol Ther. 2003; 3 : 733-43. https://doi.org/10.1517/14712598.3.5.733
-
Gilmore TD, Garbati MR. Inhibition of NF-
${\kappa}B$ signaling as a strategy in disease therapy. Curr Top Microbiol Immunol. 2011 ; 349 : 245-63. -
Gadaleta RM, Oldenburg B, Willemsen EC, Spit M, Murzilli S, Salvatore L, Klomp LW, Siersema PD, van Erpecum KJ, van Mil SW. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-
${\kappa}B$ signaling in the intestine. Biochim Biophys Acta. 2011 ; 1812(8) : 851-8. https://doi.org/10.1016/j.bbadis.2011.04.005 - Inami Y, Andoh T, Sasaki A, Kuraishi Y. Topical surfactant-induced pruritus: involvement of histamine released from epidermal keratinocytes. J Pharmacol Exp Ther. 2013 ; 344(2) : 459-66. https://doi.org/10.1124/jpet.112.200063
- Bunikowski R, Gerhold K, Brautigam M, Hamelmann E, Renz H, Wahn U. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int Arch Allergy Immunology. 2001 ; 125(4) : 344-8. https://doi.org/10.1159/000053836
- Baldwin AS Jr. The NF-kappaB and I kappaB proteins : new discoveries and insights. Annu Rev Immunol. 1996 ; 14 : 649-83. https://doi.org/10.1146/annurev.immunol.14.1.649
- Chen F, CastranovaV, Shi X, DemersL M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem. 1999 ; 45 : 7-17.
- Kim HH. Allergic rhinitis, sinusitis and asthma : evidence for respiratory system integration. Kor J Pediatrics. 2007 ; 50(4) : 335-9. https://doi.org/10.3345/kjp.2007.50.4.335
- Minardi T, Kapoor S, Bielory L. Complementary and alternative medicine : Herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol. 2009 ; 123 : 283-94. https://doi.org/10.1016/j.jaci.2008.12.023
- Xue CC, Li CG, Hugel HM, Story DF. Does acupuncture or Chinese herbal medicine have a role in the treatment of allergic rhinitis?. Curr Opin Allergy Clin Immunol. 2006 ; 6(3) : 175-9. https://doi.org/10.1097/01.all.0000225156.29780.36
- Brown JM, Wilson TM, Metcalfe DD. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy. 2008 ; 38(1) : 4-18.
- Cook EB, Stahl JL, Barney NP, Graziano FM. Mechanisms of antihistamines and mast cell stabilizers in ocular allergic inflammation. Curr Drug Targets Inflamm Allergy. 2002 ; 1(2) : 167-80. https://doi.org/10.2174/1568010023344733
- Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol. 2005 ; 23 : 749-86. https://doi.org/10.1146/annurev.immunol.21.120601.141025
- Bradding P, Holgate ST. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol. 1999 ; 31(2) : 119-33. https://doi.org/10.1016/S1040-8428(99)00010-4
- Nilsson G, Svensson V, Nilsson K. Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1. Scand J Immunol. 1995 : 42(1) : 76-81. https://doi.org/10.1111/j.1365-3083.1995.tb03628.x
- Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998 ; 128(2) : 127-37. https://doi.org/10.7326/0003-4819-128-2-199801150-00009
- Barnes PJ, Adcock IM. NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 1997 ; 18(2) : 46-50.
- Azzolina A, Bongiovanni A, Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta. 2003 ; 1643(1-3) : 75-83. https://doi.org/10.1016/j.bbamcr.2003.09.003
- Yamamoto Y, Yin MJ, Lin KM, Gaynor RB. Sulindac inhibits activation of the NF-kappa B pathway. J Biol Chem. 1999 ; 274(38) : 27307-14. https://doi.org/10.1074/jbc.274.38.27307
- Kim SH, Shin TY. Effect of Dracocephalum argunense on mast cell mediated hypersensitivity. Int Arch Allergy Immunol. 2006 ; 139(2) : 87-95. https://doi.org/10.1159/000090383